Corporate Advisory

PharmaDeals v4

PharmaTelevision

Industry Insight and Intelligence

 

PTV Latest

Cancer Research Technology: Keith Blundy on Collaborating with Big Pharma

More
Image of woman with pen

Register for E-Mail Updates

Email Address
Submit

Keeping You Updated

PharmaTelevision Partners with Reuters Insider to Deliver BioPharma Insight to the Global Financial Community

Oxford, UK, May 11, 2010: PharmaTelevision® announced that as of today the groundbreaking online TV channel for the BioPharma industry, is teaming up with Reuters Insider, a new interactive on-demand video platform designed to change the way financial professionals consume and distribute news, research and information.

Reuters Insider is a powerful, internet-based delivery platform that includes an innovative set of tools that are readily available from any desktop computer or even on your mobile devices. Reuters Insider also enables you to easily create and distribute your own proprietary content using little more than a standard webcam to build your brand within the global financial community in ways never before possible.

"As a content partner with Reuters Insider, this is a match made in heaven", said Doug Cookson, Commercial Director, PharmaVentures. "PharmaTelevision provides a unique service for the biopharmaceutical industry providing daily television news, analysis and feature interviews with industry leaders and the relationship with Reuters Insider now allows the Financial Communities around the world to have easy access to this content."

Anne Vindenes Allen, Managing Director, PharmaTelevision added: "This exciting relationship is now providing a clear channel for the Biopharmaceutical Industry to provide insight, particularly through our Financial Reports, in an impactful manner, to potentially hundreds of thousands of critical stakeholders in the financial sector."

PharmaTelevision is produced by professional television industry experts using professional studios worldwide as well as its own studios in the UK.. PharmaTelevision produces Open Content as well as subscription based Premium Content.

PharmaTelevision Open Content includes the Regional Report - a programme that focuses on the key locations for pharmaceutical and biotech investment, the Financial Report - a programme focused on companies and their performance and the Business Network - a series of interviews and profiles of some of the leading companies in biotech.

PharmaTelevision Premium Content includes PharmaTelevision News - a daily news and analysis programme, PharmaTelevision News Review - a programme featuring interviews, panel discussions and analysis with leading experts and leaders in our industry and the Business Report - a programme that analyses key business and market trends in our industry.

PharmaTelevision® is a registered Trade Mark of PharmaVentures Ltd. For more information contact:

Doug Cookson, Commercial Director, PharmaVentures Ltd.

+44 (0)1865 332 731.

doug.cookson@pharmaventures.com

- ends -

Note to Editors

PharmaVentures Limited (http://www.pharmaventures.com) is a leading international corporate advisory firm supporting its clients' growth ambitions in the health care industry. It has considerable experience and expertise in the field of tangible and intangible transactions, providing advice at both a strategic level, as well as acting as advisor and broker at an implementation level. Its transactional experience includes licensing, joint ventures, mergers, acquisitions and divestments. Its clients are worldwide, including Europe, the USA and AsiaPacific. Clients range from start-ups to global pharmaceutical corporations, diversified industrial corporations, investment houses and government bodies. Its subsidiary PharmaTelevision produces the highly popular PharmaDeals® range of intelligence products including analysis tools and reports as well as the world's first dedicated online pharmaceutical television channel PharmaTelevision® (http://www.pharmatelevision.com).

Now in its 18th year, PharmaVentures is based in Oxford, UK, and employs over 30 people.